[PHARMA] QoQ TTM Result on 30-Sep-2017 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- -23.31%
YoY- -50.1%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 2,388,351 2,323,589 2,323,960 2,293,580 2,234,292 2,248,121 2,189,022 5.99%
PBT 75,814 73,994 73,064 57,267 61,919 73,256 72,017 3.49%
Tax -26,481 -20,676 -18,077 -25,268 -21,162 -26,609 -26,158 0.82%
NP 49,333 53,318 54,987 31,999 40,757 46,647 45,859 5.00%
-
NP to SH 48,260 52,386 53,723 31,187 40,668 46,143 45,599 3.86%
-
Tax Rate 34.93% 27.94% 24.74% 44.12% 34.18% 36.32% 36.32% -
Total Cost 2,339,018 2,270,271 2,268,973 2,261,581 2,193,535 2,201,474 2,143,163 6.02%
-
Net Worth 519,642 524,838 526,888 531,892 542,147 544,360 531,169 -1.45%
Dividend
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Div 51,929 51,913 49,290 41,490 38,883 41,456 41,442 16.27%
Div Payout % 107.60% 99.10% 91.75% 133.04% 95.61% 89.84% 90.88% -
Equity
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Net Worth 519,642 524,838 526,888 531,892 542,147 544,360 531,169 -1.45%
NOSH 259,821 259,821 259,821 259,821 259,400 259,219 259,377 0.11%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin 2.07% 2.29% 2.37% 1.40% 1.82% 2.07% 2.09% -
ROE 9.29% 9.98% 10.20% 5.86% 7.50% 8.48% 8.58% -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 919.23 894.30 895.38 883.98 861.33 867.27 844.83 5.80%
EPS 18.57 20.16 20.70 12.02 15.68 17.80 17.60 3.65%
DPS 20.00 20.00 19.00 16.00 15.00 16.00 16.00 16.08%
NAPS 2.00 2.02 2.03 2.05 2.09 2.10 2.05 -1.63%
Adjusted Per Share Value based on latest NOSH - 259,821
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
RPS 165.71 161.22 161.25 159.14 155.02 155.98 151.88 5.99%
EPS 3.35 3.63 3.73 2.16 2.82 3.20 3.16 3.98%
DPS 3.60 3.60 3.42 2.88 2.70 2.88 2.88 16.08%
NAPS 0.3605 0.3642 0.3656 0.369 0.3762 0.3777 0.3685 -1.45%
Price Multiplier on Financial Quarter End Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 29/06/18 30/03/18 29/12/17 29/09/17 30/06/17 31/03/17 30/12/16 -
Price 2.88 4.28 4.60 4.14 4.58 4.89 5.30 -
P/RPS 0.31 0.48 0.51 0.47 0.53 0.56 0.63 -37.75%
P/EPS 15.51 21.23 22.22 34.44 29.21 27.47 30.12 -35.83%
EY 6.45 4.71 4.50 2.90 3.42 3.64 3.32 55.88%
DY 6.94 4.67 4.13 3.86 3.28 3.27 3.02 74.40%
P/NAPS 1.44 2.12 2.27 2.02 2.19 2.33 2.59 -32.45%
Price Multiplier on Announcement Date
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Date 17/08/18 16/05/18 27/02/18 15/11/17 16/08/17 16/05/17 21/02/17 -
Price 3.11 4.07 4.04 3.82 4.19 4.72 5.05 -
P/RPS 0.34 0.46 0.45 0.43 0.49 0.54 0.60 -31.59%
P/EPS 16.74 20.19 19.52 31.78 26.73 26.52 28.70 -30.25%
EY 5.97 4.95 5.12 3.15 3.74 3.77 3.48 43.44%
DY 6.43 4.91 4.70 4.19 3.58 3.39 3.17 60.44%
P/NAPS 1.56 2.01 1.99 1.86 2.00 2.25 2.46 -26.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment